US FDA agrees to abridged clinical Phase III for Wockhardt’s WCK 5222
A combination of Zidebactam and Cefepime, WCK 5222 represents a new class of antibiotic treatment for AMR
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Sayre Therapeutics in agreement with GP Pharm
Sayre Therapeutics will be able to distribute, market and sell LUTRATE Depot in one and three month formulations for India, Sri…
Strand Life Sciences releases version 3.0 of Strand NGS
Strand NGS 3.0 release with processing improvements promise 2x speedup compared to the global benchmark
Cipla Foundation to mark World Autism Awareness Day
Teams in Cipla offices across the globe will dress up in blue and join social media campaigns
Biocon Academy Alumni Day Meet throws up insights into future of biotech industry
Over 100 graduates of the Academy attended the Alumni Day celebrations to reminisce and relive the fun days they had spent in…
Mankind forays into diagnostics with Pathkind
To invest Rs 305 crores in the new venture which will begin operations from August 2017
US FDA approval for Dupixent, targeted biologic therapy for atopic dermatitis
Dupixent will be available later this week to the US patients suffering from this chronic and debilitating form of eczema
DRL in agreement with Integra LifeSciences
To market and distribute DuraGen Plus and Suturable DuraGen Dural Regeneration in India
Dr Reddy's Laboratories (DRL) and Integra…
Merck advances lab water purification technology with Milli-Q IQ 7000 System
Smaller, ergonomic design reduces waste, increases productivity, accelerates research
Merck announced the global launch of the…
Almirall and Sun Pharma announce regulatory filing of tildrakizumab in Europe
Pivotal Phase 3 data demonstrated potential of Tildrakizumab to offer patients treatment for moderate-to-severe plaque psoriasis…
Aptar Pharma’s multidose ophthalmic squeeze dispenser available in the US
The company is working closely with eye care specialist Allergan to improve patient safety, achieve dosing accuracy and maintain…
SGLT-2 inhibitors significantly reduce death and hospitalisations for heart failure: Astrazeneca…
The study of more than 300,000 patients with type-2 diabetes showed treatment with SGLT-2 inhibitors reduced all-cause mortality…
Divis Labs gets US FDA import alert
The company has announced that it is working with third party consultants to address concerns of USFDA
Piramal buys Mallinckrodt’s pain drug portfolio
Piramal’s critical care business is a global player in the hospital generics segment
Taro Pharmaceuticals in agreement with Thallion Pharmaceuticals
To acquire all of the issued and outstanding shares of Thallion Pharmaceuticals
TA Associates invests in Ideal Cures
Ideal Cures aims to leverage TA’s networking and other corporate development capabilities to accelerate growth
Pharma industry appreciates MoHF&W’s move on National Health Policy
"National Health Policy is a forward looking policy which would revive India's healthcare system by ensuring that Indians have…
Govt gets Rs 672 Crs fine from pharma cos for overcharging
Since inception, the NPPA has issued 1,527 demand notices to companies for overcharging
Eli Lilly India launches Humalog 200U/mL KwikPen
The pen offers physicians an alternative that allows patients to inject 50 per cent less insulin volume
DSM Sinochem Pharmaceuticals in agreement with Sandoz
The agreement will licence certain DSP intellectual property assets for the manufacture of beta lactam antibiotics